radiopharmaceuticals

News

Two players in the radiopharma sector, Curium and Lantheus, have agreed to merge and create an end-to-end player in diagnostics and therapeutics.

News

This week's round-up of private financings in the biotech arena features AdvanCell, alongside Draig, Drug Farm, MindRank AI, and Alchemab.

Oncology

Dr Andrew Cavey, CEO of ITM, discusses current and future radiopharmaceutical trends.

Oncology

Dr Philip Kantoff, a world-renowned prostate cancer clinician and researcher, discusses alpha radiopharma treatment possibilities.

News

Novartis has reported new data to support its drive to expand the label of its radioligand therapy Pluvicto in prostate cancer.

Oncology

Radiopharmaceuticals are rapidly becoming one of the most dynamic areas of oncology drug development.